Alnylam Pharmaceuticals, Inc.

NEW YORK LIFE INVESTMENT MANAGEMENT LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

1,745

Value ($000)

694

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	694	0.0%	1,745	12/31/2025
2025 Q3	11/6/2025	743	0.0%	1,629	9/30/2025
2025 Q2	8/1/2025	686	0.0%	2,103	6/30/2025
2025 Q1	5/8/2025	598	0.0%	2,214	3/31/2025
2024 Q4	2/5/2025	561	0.0%	2,384	12/31/2024
2024 Q3	11/7/2024	614	0.0%	2,231	9/30/2024
2024 Q2	8/5/2024	550	0.0%	2,263	6/30/2024
2024 Q1	5/6/2024	331	0.0%	2,218	3/31/2024
2023 Q4	2/6/2024	421	0.0%	2,198	12/31/2023
2023 Q3	11/8/2023	394	0.0%	2,226	9/30/2023
2023 Q2	8/7/2023	458	0.0%	2,413	6/30/2023
2023 Q1	5/8/2023	501	0.0%	2,503	3/31/2023
2022 Q4	2/10/2023	573	0.0%	2,413	12/31/2022
2022 Q3	11/10/2022	489	0.0%	2,442	9/30/2022
2022 Q2	8/12/2022	397	0.0%	2,725	6/30/2022